Advertisement

Topics

Debiopharm International SA Strengthens Compliance and Clinical Trial Oversight with Veeva Vault eTMF

07:03 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Global biopharmaceutical company enables real-time inspection readiness and improves CRO collaboration Veeva Systems (NYSE: VEEV) announced today that Debiopharm International SA, part of Swiss-based biopharmaceutica...

Other Sources for this Article

Veeva Systems Inc.
Sue Glanville
sue@catalystcomms.co.uk
+44 (0) 7715 817589
or
Cate Bonthuys
cate@catalystcomms.co.uk
+44 (0) 7746 546773
or
Debiopharm International SA

Christelle von Büren
+41 (0)21 321 01 11
christelle.vonburen@debiopharm.com

NEXT ARTICLE

More From BioPortfolio on "Debiopharm International SA Strengthens Compliance and Clinical Trial Oversight with Veeva Vault eTMF"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...